Effect of Evolocumab on Lipoprotein(a) and PCSK9 in Healthy Individuals with Elevated Lipoprotein(a) Level

Background and aims: The aim of this study was to investigate the influence of a single injection of Evolocumab on the dynamics of Lp(a), fractions of apoB100-containing lipoproteins, PCSK9, and their complexes in healthy individuals with elevated Lp(a) levels. Methods: This open-label, 4-week clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Afanasieva, Olga, Ezhov, Marat V., Klesareva, Elena, Razova, Oksana, Chubykina, Uliana, Egiazaryan, Mane, Sherstyuk, Ekaterina, Afanasieva, Marina, Utkina, Elena, Pokrovsky, Sergei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712661/
https://www.ncbi.nlm.nih.gov/pubmed/33076542
http://dx.doi.org/10.3390/jcdd7040045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712661/
https://www.ncbi.nlm.nih.gov/pubmed/33076542
http://dx.doi.org/10.3390/jcdd7040045

Ejemplares similares